Compare SEB & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEB | PTCT |
|---|---|---|
| Founded | 1918 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.5B |
| IPO Year | 1994 | 2006 |
| Metric | SEB | PTCT |
|---|---|---|
| Price | $5,750.00 | $68.66 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $80.65 |
| AVG Volume (30 Days) | 12.5K | ★ 824.3K |
| Earning Date | 04-27-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.15% | N/A |
| EPS Growth | ★ 467.71 | 264.48 |
| EPS | ★ 514.46 | 7.78 |
| Revenue | ★ $5,809,000,000.00 | $264,734,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.02 |
| P/E Ratio | $11.59 | ★ $9.13 |
| Revenue Growth | 7.99 | ★ 36.19 |
| 52 Week Low | $2,437.00 | $35.95 |
| 52 Week High | $5,974.03 | $87.50 |
| Indicator | SEB | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 62.55 | 50.76 |
| Support Level | $4,800.50 | $64.00 |
| Resistance Level | N/A | $69.23 |
| Average True Range (ATR) | 199.64 | 2.13 |
| MACD | 41.03 | 0.53 |
| Stochastic Oscillator | 79.26 | 52.79 |
Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.